Skip to content

Multi-Target Pallidal and Thalamic Deep Brain Stimulation for Hemi-Dystonia

Multi-Target Pallidal and Thalamic Deep Brain Stimulation for Hemi-Dystonia

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02982304
Enrollment
4
Registered
2016-12-05
Start date
2015-01-31
Completion date
2021-12-31
Last updated
2020-11-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Dystonia, Dystonia, Secondary

Brief summary

Dystonia is increasingly being considered as a multi-nodal network disorder involving both basal ganglia and cerebellar dysfunction. The aim of this study is to determine if Multi-Target Thalamic and Pallidal Deep Brain Stimulation improves hemi-dystonia patients who are receiving inadequate therapy from GPi DBS.

Interventions

DEVICEDeep Brain Stimulation

Deep Brain Stimulation Electrode

Sponsors

University of British Columbia
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Caregiver, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

1. Diagnosed with hemi-dystonia secondary to stroke 2. Candidate for GPi DBS 3. Able to provide informed consent

Exclusion criteria

1. History of intracranial pathology (such as multiple sclerosis, tumors, or aneurysms) that may account for dystonia or essential tremor. 2. History or evidence of ongoing psychiatric or neurodegenerative disorders (such as Parkinson's disease, Alzheimer's disease). 3. Incompetent adults or those unable to communicate.

Design outcomes

Primary

MeasureTime frame
Burke Fahn Marsden Disability Rating Scale (BFMDRS)3 months
SF-36 Quality of Life Scale3 months
Adverse effects of Vim or Vim + GPi Neuromodulation3 months

Countries

Canada

Contacts

Primary ContactChris Honey, MD,DPhil,FRCSC
chris.honey@telus.net604-875-5894
Backup ContactLeah Polyhronopoulos, BSc
leahpoly@mail.ubc.ca778-938-6127

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026